Genome-wide Association Studies-GWAS
Pharmacogenomics: Identification of New Drug Targets
Genetic Screens
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 7, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
D M Gagnon1, E Pergament, B A Fine
1, .
A nationwide screening program identified 3.4% of participants with Gaucher disease. Common symptoms included fatigue, bone pain, and bruising, highlighting the need for increased disease recognition.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Main Results:
Conclusions: